Literature DB >> 4691095

PKU screening-is it worth it?

.   

Abstract

Ontario's program for PKU screening of newborn infants reached 94.5% of the newborn population from 1966 to 1971. There were 70 infants identified by the program, 47 of whom were classical cases and 23 atypical cases of phenylketonuria. The incidence was 1:16,700 live births for classical cases and 1:34,000 live births for atypical cases. Since the beginning of the program 44 children have been identified in infancy as having PKU and have been treated successfully. Retardation has become evident in only three infants, two of whom were missed by the screening program.The cost of identification and care of one child for five years is about $7000, much less than the $250,000 needed to provide lifetime institutional care for one severely retarded individual.

Entities:  

Mesh:

Year:  1973        PMID: 4691095      PMCID: PMC1941175     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  4 in total

1.  Newborn screening in North America.

Authors:  Bradford L Therrell; John Adams
Journal:  J Inherit Metab Dis       Date:  2007-07-23       Impact factor: 4.982

2.  'The checkup': why, what, when, how.

Authors:  V J Thorsteinson
Journal:  Can Fam Physician       Date:  1977-06       Impact factor: 3.275

3.  Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.

Authors:  J Lord; M J Thomason; P Littlejohns; R A Chalmers; M D Bain; G M Addison; A H Wilcox; C A Seymour
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

Review 4.  Prioritising the application of genomic medicine.

Authors:  Brett Doble; Deborah J Schofield; Tony Roscioli; John S Mattick
Journal:  NPJ Genom Med       Date:  2017-11-21       Impact factor: 8.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.